CBL and breast cancer: Consequently, CBL protein levels were decreased in MCF-7 and MBA-MD-231 cells by the introduction of miR-124-3p, while the antisense of miR-124-3p significantly increased the CBL protein levels in these two breast cancer cell lines (Fig. 3b and c).